Navigation Links
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert
Date:4/3/2017

MARLBOROUGH, Mass., April 3, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms of the base indenture governing the notes dated as of December 10, 2007, as supplemented by the third supplemental indenture dated as of March 5, 2012 (collectively, the indenture).

The conversion right has been triggered because the closing price of the Company's common stock exceeded approximately $40.53, which is 130% of the conversion price for the notes, for at least 20 of the 30 consecutive trading days ending on March 31, 2017.  As a result, the notes are convertible until June 30, 2017, subject to the terms, conditions and adjustments in the indenture and the notes. The notes may continue to be convertible after June 30, 2017 if one or more conditions specified in the indenture are satisfied during future measurement periods.

The current conversion rate for the notes is 32.07698 shares of the Company's common stock per $1,000 principal amount outstanding, which is equivalent to a conversion price, as defined in the indenture, of approximately $31.18 per share. The Company may elect to satisfy its conversion obligation in shares of common stock, cash, or a combination of cash and shares in accordance with the terms, procedures and conditions outlined in the indenture and the notes.

None of the Company, its board of directors, or employees has made, or is making, any representation or recommendation to any holder of the notes as to whether or not to exercise the conversion right.

Holders of the notes who have questions or wish to exercise their conversion right should contact Wilmington Trust Company at:
Wilmington Trust Company
Rodney Square North
1100 North Market Street
Wilmington, DE  19890
Attention: Workflow Management, 5th Floor
Telephone:  (302) 636-6470

A complete explanation of the conversion right, as well as the procedures required to convert notes, is set forth in the indenture.  Holders are urged to review the conversion procedures contained in the notes and the indenture.  The base indenture was filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on December 10, 2007.  The third supplemental indenture was filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 8, 2012.

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems for breast and skeletal health, GYN surgical products, and medical aesthetic systems.  With a broad range of market-leading technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.  For more information on Hologic, visit www.hologic.com.

Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Contact

Michael Watts
Vice President, Investor Relations and
Corporate Communications
(858) 410-8588

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hologic-delivers-notice-that-holders-of-200-convertible-exchange-senior-notes-due-2042-are-eligible-to-convert-300433571.html


'/>"/>
SOURCE Hologic, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Medical Appliances Stocks Under Scanner -- Neovasc, Hologic, Edwards Lifesciences, and Sunshine Heart
2. Hologic Completes Acquisition of Cynosure
3. Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses
4. Technical Reports on Medical Equipment Equities -- Edwards Lifesciences, Accuray, Hologic, and Zimmer Biomet
5. Hologic Announces Financial Results for First Quarter of Fiscal 2017
6. Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
7. Medical Equipment Stocks on Investors Radar -- Hologic, St. Jude Medical, Edwards Lifesciences, and Zimmer Biomet
8. Research and Markets - Global Hysteroscopes Market 2016-2020: Limitations in Open Surgery Will Drive Growth of Hysteroscopes with Hologic, Karl Storz, Olympus Medical & Stryker Dominating
9. Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
10. Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016
11. FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)... Ind. , Sept. 1, 2017  Explorers Like Us ... capture America,s greatest aural experiences — and deliver these experiences ... experience to help people feel and heal better. ... While nothing beats a ... and refresh your mind, Life Environments™ is the next best ...
(Date:8/29/2017)... Va. , Aug. 29, 2017 ivWatch, LLC, the ... peripheral IV infiltrations, announced it has been awarded an Innovative Technology ... company in the country. ... continuous monitoring device to aid in the early detection of peripheral ... The Innovative ...
Breaking Medicine Technology:
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time client ... (OCR) HIPAA audit and properly satisfy the law. , Thanks to the help ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on ... to better one’s life through God. “The Trials I Face to Receive God’s Grace” ... places, found a love for writing. Green feels that expressing his feelings through prayer ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
Breaking Medicine News(10 mins):